Sophie's story
Sophie was ten years old when she was diagnosed with a Wilms tumour on her left kidney. Her mum, Rebecca, shares their story.
Finley's story
Finley was diagnosed with acute lymphoblastic leukaemia (ALL) in December 2018 when he was seven years old. His mum, Natasha, shares his story.
New Innovation Grants funded in partnership with the Little Princess Trust
The Little Princess Trust (LPT) has announced three new research projects will be funded by its prestigious Innovation Grant. Awarded in partnership with Children’s Cancer and Leukaemia Group, LPT’s Innovation Grant aims to fund promising and inspired new research ideas.
Mollie's story
Mollie was diagnosed with parameningeal embryonal rhabdomyosarcoma in 2018, just one month before her third birthday. Her mum, Fiona, shares her story.
Finding a cure for childhood cancer: celebrating CCLG's research impact
We published our first Research Impact Report this year to celebrate CCLG's progress towards finding a cure for children's cancer. As readers of Contact magazine, we are delighted to share extracts from this report in this 4-page supplement for Contact readers.
The role of a chief investigator in a clinical trial
Professor Bruce Morland is a recently retired paediatric oncologist from Birmingham Children’s Hospital. Here, he tells us about his work as a chief investigator on a global clinical trial.
How patients and families are helping prioritise research
The Children’s Cancer Priority Setting Partnership (PSP) aims to identify gaps in research and ‘unanswered questions’ on children’s cancer by including patients and parents. Susie Aldiss, Prof Faith Gibson and Dr Jess Morgan, of the project team, explain more.
Why we chose to enter a clinical trial
Katy Jones' daughter Eden was three years old when she was diagnosed with leukaemia in July 2017. She explains some of the things her family considered before deciding on entering into a clinical trial.
A parent's view... joining a trial
Carrie Wright’s daughter, Lucy, was diagnosed with neuroblastoma in August 2018. She writes on participating in the international MiNivAN clinical trial and offers advice to others faced with making decisions about their child’s treatment.